Clinical application of the HFA/ICOS score in breast cancer women: its added value in the prediction of chemotherapy-related cardiac dysfunction

Back

ESC Professional Premium Access

Clinical application of the HFA/ICOS score in breast cancer women: its added value in the prediction of chemotherapy-related cardiac dysfunction

Session: Cardiovascular risk in patients with cancer

Topic: Cardio-Oncology

Speaker: Associate Professor G. Novo (Palermo, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Associate Professor Giuseppina Novo

University of Palermo, Palermo (Italy)

3 presentations

1 follower

5 more presentations in this session

Association between fasting glucose and cardiovascular disease mortality in cancer survivors: a population-based study

Speaker: Doctor M. Jung (Seoul, KR)

Anti-diabetic medication adherence and cardiovascular outcomes in patients with cancer: a nationwide population-based cohort study

Speaker: Doctor M. Jung (Seoul, KR)

Is staging for cardiac damage in aortic stenosis associated with MACE in cancer patients with prior radiotherapy or chemotherapy that underwent transcatheter aortic valve replacement?

Speaker: Doctor S. Santos Patarroyo (Rochester, US)

The Dutch Cardio-Oncology cohort: Incidence of cardiovascular disease predisposes to a higher cancer mortality rate.

Speaker: Assistant Professor Y. Koop (Utrecht, NL)

Cardiac CARE study: How the ESC Cardio-Oncology guidelines fo 2022 affect the study population

Speaker: Doctor K. Loganath (Edinburgh, GB)

Access the full session

Cardiovascular risk in patients with cancer

Speakers: Associate Professor G. Novo, Doctor M. Jung, Doctor M. Jung, Doctor S. Santos Patarroyo, Assistant Professor Y. Koop...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources